from The Jackson Laboratory, Bar Harbor, ME, or were bred in our colony from Jackson Laboratory breeding stock. All mice used as donors of responder and stimulator cells were sex matched. Responder cells were obtained from mice 6-14 wk of age.
In Vitro Generation of CTL. CTL were generated using a modification of previously described procedures (12) . Preliminary experiments demonstrated that higher levels of cytolysis could be obtained by increasing the concentration of stimulator cells from our standard density of 5 × 105/ml to a density of 2-3 × 106/ml. Thus, unprimed responder cells and irradiated H-2-compatible stimulator cells were mixed in equal numbers at a final cell density of 4-6 × 106/ ml, and cultured for 6 d at 37°C in a humidified atmosphere of 5% CO2 in air. The culture medium was Eagle's minimum essential medium with Hanks' balanced salt solution, supplemented as described (12) , with 5% fetal calf serum (Gibco Laboratories, Grand Island, NY), and 2 × 10 -2 M 2-mercaptoethanol (Eastman Kodak Co., Rochester, NY).
Assay for CTL Activity. Target cells were ~lCr-labeled concanavalin A-stimulated spleen cells, prepared as previously described (12) . Targets were plated at a density of 20,000 viable cells per well in 96-well round-bottomed tissue culture plates (Flow Laboratories, Rockville, MD). Cold targets were concanavalin A blasts prepared in the same manner, but not labeled. Effector cells and cold targets were adjusted for viability and added, in doubling dilutions, to the wells containing hot targets. The cells were incubated for 4-6 h at 37°C and harvested using the Titertek Supernatant Collection System (Flow Laboratories). Data are expressed as: percent net Cr release --([experimental release -spontaneous release]/[maximum release -spontaneous release]) × 100, where the spontaneous release is the activity released from hot target cells in medium alone, and the maximum release is the activity released from hot target cells lysed with 0.5% sodium dodecyl sulfate, or by three cycles of freezing and thawing.
Results
We first compared the specificity of NZB and (NZB × B10.D2)F1 primary CTL responding to H-2-compatible stimulators (Fig. 1) . As previously reported (12) , the NZB CML response to H-2 a stimulator cells was Qa-1.2 specific, as demonstrated by the differential lysis of targets from the Qa-Tla region congenic pair B6 (//-2 b, Qa-16) and B6-Tla a (H-2 b, Qa-1 a) (Fig. 1 A) . The greater degree of lysis of BALB/c targets than of B6 targets is consistent with H-2-restricted, minor histocompatibility antigenspecific cytolysis, as reported by others (10, 11, 13) . We confirmed that (NZB × B 10.D2)Fx anti-BALB/c CTL can also be generated in a primary response, and the the cytolysis was H-2-unrestricted, with lysis of both H-2 b targets tested (Fig. 1 B) . As expected, the Qa-l-heterozygous responders did not recognize Qa-l. Because of the H°2-unrestricted nature of the F1 primary CML response, and the report of secondary H-2-unrestricted lysis of cells bearing a maternally transmitted antigen (9), we asked whether Qa-l-heterozygous F1 CTL could recognize Mta in a primary response. To study Mta-specific CTL, we assayed for lysis of targets from reciprocal F1 females that share the same complement of chromosomes, but differ in their expression of Mta. Fischer Lindahl et al. (9) reported that Mta + mothers bear Mta + progeny, regardless of the male partner's phenotype. Similarly, Mta-mothers bear only Mta-progeny. All inbred strains typed by Fischer Lindahl et al., except NZB, z were Mta +. Thus, (NZB X B10.D2)F1 mice are Mta-, but the reciprocal 20utbred NMRI mice are also Mta-. However, two sublines of the NZB strain, NZB/Fiill and NZB/BIPt, typed positive for Mta. In all experiments shown, we used the Mta-subline NZB/BINJ. Similar results have been obtained with the NZB/N subline, which was not typed by Fischer Lindahl et al. (9) . , were lysed at a much lower level. On the other hand, differential lysis of reciprocal F1 targets was not observed when the CTL were generated from (B10.D2 × NZB)FI anti-BALB/c cultures, in which both responder and stimulator cells were Mta + (Fig. 2 B) . In addition, the Mta + F1 CTL did not lyse the non-H-2 a targets (B6 and B6-Tlaa). The low levels of lysis on syngeneic and other H-2 a targets was observed in approximately one-half of our experiments with the Fa responders. This may represent H-2-restricted lysis specific for serum components or for virus on the blasts used as targets.
Although the lysis of H-2 b targets (B6 and B6-Tla a) in Fig. 2A demonstrated 1-1-2 unrestricted lysis, it was important to demonstrate specifically that the lysis of the Mta ÷ Wl targets was not restricted by the H-2a-encoded determinants shared with the effectors. Cold target inhibition experiments were performed to address this issue (Fig.  3) . Lysis of the 51Cr-labeled target, C57BL/10 (B10, H-2 b, Mta+), was inhibited by cold targets from the Mta + (B10.D2 × NZB)FI, but not by those from Mta-(NZB X B 10.D2)F1. Thus, the relevant antigen recognized by H-2-unrestricted CTL on the B 10 targets is the same as that recognized on the Mta + Fa targets.
Discussion
The nature of the target antigens for NZB anti-H-2 a primary CTL has been a subject of controversy. Although most investigators agree that Qa-1.2 is a major target antigen and that H-2-restricted minor histocompatibility antigen-specific lysis may occur, not all data can be accounted for by these findings. A particularly intriguing observation is that H-2-unrestricted, non-Qa-l.2-specific cytolysis has been detected in (NZB × B10.D2)F1 responses (13, 15) . The data presented in this report strongly suggest that Mta is a major target antigen for such responses. The differential lysis of reciprocal F1 target cells by H-2-unrestricted CTL demonstrates specificity for an antigen that is indistinguishable from that described by Fischer Lindahl et al. (9) for NZB secondary CML responses. In that report, the investigators did not detect Mtaspecific lysis in NZB primary CML responses. However, other investigators have reported H-2-unrestricted lysis of Qa-l a target cells by primary NZB CTL (10, 11, 13, 14) . We observed low levels of such lysis in approximately one-third of our NZB primary CML responses to H-2-compatible stimulators. In those experiments, we detected greater lysis on Mta + (B10.A × NZB)F1 targets than on Mta-(NZB × B10.A)F1 targets (our unpublished observations). Thus, Mta-specific CTL can also account for the low level of lysis detected on Qa-1 a, non_H_2 a target cells in the NZB primary CML response. In all paired comparisons of NZB and (NZB X B10.D2)F1 responses, Mta-specific lysis by the Qa-1 a/b F1 CTL was always greater than that by the NZB CTL (compare lysis of the B6-Tla a target in panels A and B, Fig. 1 ). Absence of foreign Qa-1 determinants in the stimulator population may therefore be a requirement for generating a strong primary Mta-specific response, The finding that the Qa-1 heterozygous (NZB × B 10.D2)F1 hybrids respond to Mta may clarify much of the controversy regarding the specificity of the NZB primary CML response. When NZB cells are stimulated with H-2-compatible stimulators, the major target antigen is Qa-l.2, although Mta-specific and H-2-restricted minor antigen-specific lysis may also occur. The same pattern holds for Qa-l%homozygous F1 responders (e.g., [NZB × B 10.BR)F1; our unpublished observations]. However, if the F1 responder is a Qa-1 heterozygote, the specificity depends on whether the Fa expresses Mta. H-2-restricted lysis occurs regardless of the Mta phenotype of the responder, and is the only reactivity seen for the Mta + responder. But for the Mta-F1, H-2-unrestricted, Mta-specific lysis is the major component of the response.
That the NZB response is directed against a complex set of target antigens has important implications for studying the genetics of NZB hyperreactivity in the primary CML response. Because F1 and backcross mice may not recognize as foreign the same antigenic determinants that the parental NZB mice recognize, one might mistake genes, such as Qa-l, that determine antigenic disparity for those that determine hyperreactivity. The finding that one of the target antigens does not segregate in Mendelian fashion makes such considerations even more important. Davidson et al. (13) , studying the response of (NZB × B 10.D2)F1 mice and their backcrosses to the B 10.D2 parent, concluded that two genes control the response to non-Qa-1 antigens, and that one or both of these genes is semidominant, because the response of the F1 mice was intermediate between that of the NZB and B 10.D2 parents. An alternative explanation for the intermediate level of F1 responsiveness is that the F1 and NZB CTL respond to different stimulator cell antigens, because the F1 mice were Qa-1 heterozygotes. The inability of those particular F1 mice to recognize the major target antigen for the parental NZB response, rather than gene dosage effects, may have caused the lower magnitude of the F1 response. When the F1 generation is Qa-1 ahomozygous [e.g., (NZB × B10.BR)F@ the response is Qa-l.2-specific and the magnitude is equal to that of the NZB parent, suggesting that hyperresponsiveness to Qa-l.2 is a dominant effect (our unpublished observations). Thus, in studying the genetics of NZB hyperreactivity in the primary CML response, it is necessary to take into account not only the magnitude of the response, but also whether the Fa and backcross mice are capable of recognizing Qa-1.2 or Mta as foreign determinants on the stimulator cells. Summary Mta-specific cytotoxic T lymphocytes (CTL) can be generated in primary cultures of (NZB × B 10.D2) F1 spleen cells with H-2-compatible BALB/c stimulator cells. The CTL lyse reciprocal Mta + (B 10.D2 × NZB)Fa as well as H-2-disparate targets, such as B10, B6, and B6-Tlaa; they do not lyse targets from NZB or any F1 hybrid of an NZB mother. The lysis of51Cr-labeled B I0 targets is completely inhibited by unlabeled targets from Mta + (B10.D2 × NZB)F1, but not from the reciprocal Mta-F1, thus demonstrating H-2-unrestricted lysis of Mta.
